InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by BROWN JAMES F, Director. Director active across 1 companies, notably Bellicum Pharmaceuticals, INC. Aggregated, 2 disclosures have been logged. The latest transaction was filed on 4 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
028,384 shares0
Common Stock
SEC:0001628280-22-000415:0·
028,384 shares0
Common Stock
SEC:0001628280-22-000415·
2 of 2 declarations
About BROWN JAMES F
James F. Brown is a Board Member at Bellicum Pharmaceuticals, Inc. He plays a key role in overseeing the company's activities and developing its strategy. Bellicum Pharmaceuticals, Inc. is a biopharmaceutical company focused on innovation in cancer treatment.
